Foodborne illnesses and product liability in the U.S.
نویسندگان
چکیده
Abstract A regulatory liability-based approach to reducing foodborne illnesses is widely used in the U.S. But how effective it? We exploit regime variation across states and over time examine relationship between product liability laws reported illnesses. find a positive statistically significant strict with punitive damages number of find, however, no illness-related hospitalizations deaths.
منابع مشابه
Risk factors for foodborne bacterial illnesses during Ramadan
Introduction: In the holy month of Ramadan, Muslims abstain from eating and drinking during daytime and mostly take two meals per day. One of these major meals is consumed before sunrise (Sahur), and the other is taken after sunset (Iftar). The partial nutritional deprivation in Ramadan may affect the immune system, while the other rituals of this month might render fasting individuals suscepti...
متن کاملProduct liability.
Product liability litigation has made important contributions to tobacco control, especially by uncovering incriminating industry documents and publicizing product dangers and industry misconduct. WHO Framework Convention on Tobacco Control (FCTC) Article 19 encourages Parties to strengthen legal procedures to facilitate these lawsuits and to establish mechanisms for mutual assistance. Creative...
متن کاملThe Pharmaceutical Industry and Product Liability Exposures
In the broadest sense, the Pharmaceutical Industry comprises various different business models which cover all or only some parts of the pharmaceutical product life cycle. Traditionally, the pharmaceutical industry segment was constituted by research-based pharmaceutical companies which had an integrated business model from the research laboratory to distribution, meaning they developed, manufa...
متن کاملPharmaceutical Product Liability
Product liability is one of the fastest growing and most economically significant applications of tort law. Product liability actions against pharmaceutical companies are among the most widely publicized classes of suits in the United States and Europe, prompting pharmaceutical companies to lobby vigorously for tort reform. (Nace et al., 1997). The liability burden on pharmaceutical companies h...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Agricultural and Resource Economics Review
سال: 2022
ISSN: ['1068-2805', '2372-2614']
DOI: https://doi.org/10.1017/age.2022.25